Engineered antibody helps block SARS-CoV-2 transmission

Researchers at UC Davis Health have engineered a novel antibody, FuG1, that can directly interfere with the cell-to-cell transmission ability of SARS-CoV-2, the virus that causes COVID-19.

Big data kinase ohmics takes over drug discovery

In order for tumors to successfully take hold and spread in the body, they typically must meet several developmental milestones. These include things like suppressing apoptosis, cultivating replication and angiogenesis, weaning ...

Understanding COVID-19 infection and possible mutations

The binding of a SARS-CoV-2 virus surface protein spike—a projection from the spherical virus particle—to the human cell surface protein ACE2 is the first step to infection that may lead to COVID-19 disease. Penn State ...

Chemists discover the structure of a key coronavirus protein

MIT chemists have determined the molecular structure of a protein found in the SARS-CoV-2 virus. This protein, called the envelope protein E, forms a cation-selective channel and plays a key role in the virus's ability to ...

page 4 from 9